Infections caused by Gram-positive bacteria: a review of the global challenge (Q37600393)

21 August 2017

1 reference

title

Infections caused by Gram-positive bacteria: a review of the global challenge (English)

1 reference

21 August 2017

main subject

gram-positive bacteria

0 references

1

Neil Woodford

1 reference

21 August 2017

2

David M Livermore

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

59 Suppl 1

1 reference

21 August 2017

page(s)

S4-16

1 reference

21 August 2017

cites work

Epidemic staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

“Celbenin” - resistant Staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The evolution of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The emergence and evolution of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Detection of methicillin-resistant Staphylococcus aureus directly from nasal swab specimens by a real-time PCR assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

High-level (beta)-lactam resistance and cell wall synthesis catalyzed by the mecA homologue of Staphylococcus sciuri introduced into Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

In vivo deletion of the methicillin resistance mec region from the chromosome of Staphylococcus aureus strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Partial excision of the chromosomal cassette containing the methicillin resistance determinant results in methicillin-susceptible Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Supplementary phages for the investigation of strains of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Subtyping of methicillin-resistant Staphylococcus aureus isolates from the North-West of England: a comparison of standardised pulsed-field gel electrophoresis with bacteriophage typing including an inter-laboratory reproducibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence, spread, and characterization of phage variants of epidemic methicillin-resistant Staphylococcus aureus 16 in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Multilocus sequence typing

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Surveillance and epidemiology of MRSA bacteraemia in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Widespread dissemination in The Netherlands of the epidemic berlin methicillin-resistant Staphylococcus aureus clone with low-level resistance to oxacillin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

MRSA in livestock animals-an epidemic waiting to happen?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

United States resistance surveillance results for linezolid (LEADER Program for 2007).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The emergence of infections with community-associated methicillin resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Genome of an epidemic community-acquired MRSA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Virtual digest identification of secondary enzymes for use in pulsed-field gel electrophoresis of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The life and times of the Enterococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Enterococcus faecium low-affinity pbp5 is a transferable determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Nucleotide sequence of the beta-lactamase gene from Enterococcus faecalis HH22 and its similarity to staphylococcal beta-lactamase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Beta-lactamase-producing enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Comparison of two beta-lactamase-producing strains of Streptococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Plasmids and pheromone response of the beta-lactamase producer Streptococcus (Enterococcus) faecalis HH22.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Intrahospital spread of a single gentamicin-resistant, beta-lactamase-producing strain of Enterococcus faecalis in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Chromosomally mediated beta-lactamase production and gentamicin resistance in Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Evidence of incorporation of the chromosomal beta-lactamase gene of Enterococcus faecalis CH19 into a transposon derived from staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Novel agents for the treatment of resistant Gram-positive infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Future directions with daptomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Epidemic vancomycin-resistant Enterococcus faecium in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Two widely disseminated strains of Enterococcus faecalis highly resistant to gentamicin and ciprofloxacin from bacteraemias in the UK and Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Virulence of enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Multilocus sequence typing scheme for Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

A European study on the relationship between antimicrobial use and antimicrobial resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The relentless rise of resistance?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Horizontal spread of an altered penicillin-binding protein 2B gene betweenStreptococcus pneumoniaeandStreptococcus oralis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001, and 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Novel antibiotic-resistant pneumococcal strains recovered from the upper respiratory tracts of HIV-infected adults and their children in Kisumu, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Clonal analysis of Streptococcus pneumoniae nonsusceptible to penicillin at day-care centers with index cases, in a region with low incidence of resistance: emergence of an invasive type 35B clone among carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Impact of conjugate pneumococcal vaccines on antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Linezolid resistance in a clinical isolate of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Linezolid resistance in clinical isolates of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Linezolid-resistant enterococci: report of the first isolates in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Recombination Proficiency Influences Frequency and Locus of Mutational Resistance to Linezolid in Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Sampling the antibiotic resistome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Streptococcus pneumoniae isolates resistant to telithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

An epidemic, toxin gene-variant strain of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2809%2960003-7

7 January 2021

10.1016/S0163-4453(09)60003-7

Identifiers

DOI

1 reference

21 August 2017

1 reference